Notable Research Findings

The most groundbreaking individual studies from the latest supplement and nutrition research — in plain language, with the evidence caveats built in. Research signals worth knowing about, not health advice.

Curcumin improved prostate symptoms by more than 4 points on the IPSS scale in a meta-analysis of 697 men — but the trials were too different from each other to trust that number as universal.
- 2026-06-05
- Meta-Analysis
- n = 697
- European journal of clinical pharmacology
This is intriguing but early: a single meta-analysis suggests turmeric may help urinary symptoms, but the studies it pooled varied widely in design, and the dose remains unknown, so this isn't yet a reliable recommendation for all men.
SurprisingTurmeric for Improved International Prostate Symptom Score
A network meta-analysis of 3,116 children found medium-dose vitamin A most effective at shortening fever duration in pneumonia — but high doses and safety data remain open questions.
- 2026-04-20
- Meta-Analysis
- n = 3,116
- European journal of pediatrics
This is the first solid evidence on vitamin A for fever in pediatric pneumonia, but with limited safety data and no effect on other clinical outcomes, it's a promising lead — not a settled recommendation.
New evidenceVitamin A for Reduced Fever Duration
Collagen supplements slashed wrinkle severity with a huge effect size in a meta-analysis — but the same review found it also improved hydration, barrier function, and pigmentation, so the benefit isn't limited to wrinkles alone.
- 2025-10-31
- Meta-Analysis
- Journal of physiological anthropology
This is the first meta-analysis to quantify collagen's effect on wrinkles with a large, statistically robust effect, but because it is among the first indexed studies for this specific pairing, the finding needs replication before taking it as settled.
Big effectCollagen for Reduced Wrinkle Severity
In septic shock patients, a meta-analysis linked vitamin B1 to a 52% lower need for kidney replacement therapy — but the evidence comes from just 438 people across a handful of small trials.
- 2025-11-24
- Meta-Analysis
- n = 438
- Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
This is an early, promising signal that thiamin might protect kidneys during severe sepsis, but with so few patients and no specified dose, it’s far from a proven therapy — think intriguing clue, not settled science.
SurprisingVitamin B1 for Reduced Renal Replacement Therapy
A systematic review found turmeric and three other herbs eased depression symptoms — but the review lumped them together, so turmeric’s individual effect is unclear.
- 2024-12-09
- Systematic Review
- Frontiers in psychiatry
This is among the first indexed reviews on turmeric for depression, so the finding is intriguing but far from settled — treat it as a signal, not a solution.
Myth-busterTurmeric for Reduced Depression Symptoms
A 150-day trial of vitamin D in infertile men found it did not raise serum magnesium — a mineral the same study linked to better sperm quality.
- 2026-03
- RCT
- n = 299
- Reproductive biomedicine online
This null result chips away at the popular notion that vitamin D directly improves male fertility; the real driver of the sperm-quality benefits seen in this study may be magnesium, not vitamin D — but this is one of the first trials to test the link, so the picture is far from settled.
Myth-busterVitamin D for Increased Sperm Concentration
200 pregnant women at risk of preterm birth got a probiotic — and it worked no better than placebo.
- 2025-05-08
- RCT
- n = 200
- Biomedicines
This careful trial contradicts any popular hope that vaginal probiotics can reduce preterm birth after a threat of early labor; but because it's among the first studies on this specific strain in this narrow clinical group, the picture is now contested, not settled.
Myth-busterLactobacillus gasseri LQ-36 for Reduced Preterm Births
88% of carnitine-treated dialysis patients reduced erythropoietin resistance, versus 0% on placebo — but the effect was seen only in a small, clinical pilot trial.
- 2026-05
- RCT
- Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
This is an early, well-controlled signal that l-carnitine might help a specific group of kidney patients use less erythropoietin, but the tiny sample and narrow population mean the result is far from generalizable.
Big effectL-Carnitine for Reduced Erythropoietin Resistance Index
Probiotics cut IBS intestinal discomfort by 94 points in meta-analysis — but the benefit depended on the specific strain
- 2025-12-31
- Meta-Analysis
- Medicina (Kaunas, Lithuania)
This is among the first large analyses to quantify the effect, but the evidence for individual strains like Bifidobacterium plantarum is still emerging, so treat the overall estimate with caution.
Big effectBifidobacterium plantarum for Improved Irritable Bowel Syndrome Symptoms
Honey and propolis outperformed a standard herpes cream by a factor of 4.7 in a meta-analysis — but the comparison studies were unblinded, and the same analysis found no benefit for aborting an attack.
- 2026-01-06
- Meta-Analysis
- International journal of STD & AIDS
This is an unusually large effect from a pooled analysis, but because the trials weren’t blinded (participants knew what they were using) and this is one of the first such meta-analyses, the headline number should be treated as promising but not settled — especially since honey didn’t help stop an outbreak from starting.
Big effectHoney for Increased Healing Rate
Fish oil cut insulin resistance by 2.06 standard deviations in MASLD patients — a huge effect, but other metabolic measures like BMI and HDL didn't change.
- 2025-01-24
- Systematic Review
- n = 439
- Frontiers in nutrition
This meta-analysis provides early evidence that fish oil may powerfully improve a key marker of metabolic health in people with fatty liver disease, but the benefit appears limited to that clinical population and didn't extend to weight or cholesterol.
Big effectFish Oil for Reduced HOMA-IR
A meta-analysis of supplements for competitive swimmers found beta-alanine failed to improve performance — joining caffeine and sodium bicarbonate in the null column, with only creatine showing a statistically significant effect.
- 2025-04-09
- Meta-Analysis
- Journal of the International Society of Sports Nutrition
This is one of the first indexed meta-analyses on beta-alanine for swimming, so the null result challenges the popular belief that it helps — but the evidence base is still thin, so the picture is contested rather than settled.
Myth-busterBeta-Alanine for Improved Swimming Performance
Iron supplementation achieved the highest SUCRA ranking (56.54%) for lowering heart rate at altitude — but the benefit was not statistically significant in a systematic review of 329 people.
- 2025-11-04
- Systematic Review
- n = 329
- Frontiers in nutrition
This contradicts the common belief that iron reliably improves heart rate during high-altitude exercise, but because this is among the first systematic reviews on the specific pairing and the dose wasn't specified, the evidence is still too preliminary to change any recommendations.
Myth-busterIron for Reduced Heart Rate
Eczema incidence dropped from 67% to 26% in infants given a specific probiotic strain — but the result comes from a single Chinese trial that also saw fewer infections, leaving generalization uncertain.
- 2026-02-15
- RCT
- n = 180
- Clinical and experimental pediatrics
This is the first indexed study on Bifidobacterium animalis subsp. lactis BLa80 for eczema, so while the effect size is striking, it needs replication before we can confidently say the benefit extends beyond this population and these co-measured outcomes.
Big effectBifidobacterium bifidum Bb-02 for Reduced Eczema Incidence
A double-blind trial found that 600 mg of N-acetyl cysteine taken twice daily slashed the rate of a dangerous platelet-drop from 41.6% to 16.8% in critically ill patients on linezolid — though the results come from a single study in a very specific, sick population and need replication before they apply more broadly.
- 2026-03
- RCT
- Environmental toxicology and pharmacology
This is one of the first rigorous trials to show NAC can prevent a serious side effect of a common antibiotic, but the finding is so novel that it should be treated as promising preliminary evidence, not a settled benefit for everyone.
Big effectN-Acetyl Cysteine for Reduced Thrombocytopenia
A systematic review of 415 adults found vitamin D linked to autoimmune protection in some studies — but most trials showed no significant benefits.
- 2025-07-04
- Systematic Review
- n = 415
- BMC nutrition
This is among the first systematic reviews on vitamin D for autoimmune protection in healthy adults, so the positive finding is intriguing but far from settled — especially since most outcomes in the same review (like blood pressure and cholesterol) showed no effect.
New evidenceVitamin D for Reduced Autoimmune Reaction
Swapping half your daily staple for quinoa boosted blood-sugar time-in-range over a year — but the study was open-label, so expectations should be tempered.
- 2025
- RCT
- n = 207
- Food & function
This is one of the first long-term trials to pit quinoa directly against other whole grains, and the results are promising for people with impaired glucose tolerance — but because neither participants nor researchers knew which group they were in, the real-world advantage may be smaller than reported.
Surprisingquinoa for Increased Time in Range
Calcium tied to a 7% lower colorectal cancer risk in Asian meta-analysis — but the confidence interval crossed 1.0, meaning no statistical significance
- 2025-08-27
- Meta-Analysis
- Cancer causes & control : CCC
This is one of the first meta-analyses on calcium and colorectal cancer in Asian populations, and the borderline result means the protective effect is far from settled — treat the finding as hypothesis-generating, not conclusive.
Myth-busterCalcium for Reduced Risk of Colorectal Cancer
A meta-analysis of genetic studies found coffee consumption had no statistically significant link to liver cancer risk (OR 0.92, 95% CI 0.58–1.47) — challenging earlier observational reports that suggested a protective effect.
- 2025-08-25
- Meta-Analysis
- Gut and liver
This is among the first indexed studies using genetic data to test the coffee–liver cancer link, so the null result casts doubt on the previously believed benefit but doesn't settle the debate — more research is needed before changing any habits.
Myth-busterCoffee for Reduced Hepatocellular Carcinoma Risk
Kefir slashed HOMA-IR by 1.71 points in a meta-analysis — but the same review found no effect on weight, waist size, cholesterol, or inflammation.
- 2026-05
- Meta-Analysis
- Nutrition, metabolism, and cardiovascular diseases : NMCD
This is a large, statistically significant drop in a key marker of insulin resistance, but it comes from only three studies, and the fact that kefir didn't budge any other metabolic or inflammatory measure means the benefit appears narrow — and may not translate into the broader health improvements you'd expect.
Big effectKefir for Reduced HOMA-IR
Probiotic Bacillus coagulans increased bowel movements and improved stool consistency in a 111-person trial — but it’s one of the first solid studies on this specific pairing.
- 2025-07-22
- RCT
- n = 111
- Beneficial microbes
This is an early, well-designed trial suggesting the probiotic helps with constipation and bowel regularity, but a single study — even a rigorous one — isn’t enough to call the effect established.
New evidenceBacillus coagulans GBI-30, 6086 for Improved Gastrointestinal Function
Extremely preterm infants given L. reuteri scored 7 points higher on language at age 2 — but cognition, motor skills, and growth remained unchanged.
- 2025-02-13
- RCT
- n = 134
- Acta paediatrica (Oslo, Norway : 1992)
This early finding suggests a possible selective benefit for language, but it comes from a single trial in a fragile, clinical population — far from a general recommendation.
SurprisingLactobacillus reuteri DSM 17938 for Improved Language Score
In a 24-week trial, vitamin E failed to budge the NAFLD fibrosis score in non-diabetic MASLD patients — a -0.12 point change that didn't reach statistical significance.
- 2026-05-16
- RCT
- n = 136
- The Indian journal of medical research
This open-label trial contradicts the common notion that vitamin E helps liver scarring in fatty liver disease, but because the study was small (136 people), unblinded, and short-term, the debate is far from settled.
Myth-busterVitamin E for Reduced NAFLD Fibrosis Score
1 g/day fish oil reduced a key inflammation marker by 24% in older adults — but 2 g and 4 g doses got no extra benefit.
- 2026
- RCT
- n = 240
- Food & function
This is one of the first rigorous human trials to test low-dose fish oil on vessel-wall inflammation, but a single study in elders — even a good one — can't yet settle the dose question or prove clinical impact.
New evidenceFish Oil for Reduced ICAM-1 Level
Probiotics failed to shift Shannon diversity, species richness, or other key gut bacteria metrics in a meta-analysis of healthy adults — a null result that runs counter to popular claims.
- 2026-01-07
- Meta-Analysis
- BMC medicine
This meta-analysis pools multiple randomized trials, making it a stronger test than any single study, but because it looked at probiotics broadly, it doesn't rule out that specific strains like Pediococcus acidilactici R1001 might work in certain people or conditions — and the body of evidence for this exact pairing is still thin.
Myth-busterPediococcus acidilactici R1001 for Maintained Gut Microbiota Diversity
Probiotics halved the risk of chemotherapy-induced diarrhea in colorectal cancer patients — but the benefit didn't extend to inflammatory biomarkers.
- 2025-07-04
- Meta-Analysis
- n = 1,526
- Medicine
This is the strongest evidence yet for this specific probiotic strain in a clinical setting, but because it's among the first meta-analyses on the pairing, the results need replication before they can be generalized to all cancer patients or other probiotic formulations.
Big effectBifidobacterium infantis HA-116 for Reduced Chemotherapy-Induced Diarrhea
A meta-analysis of 16 trials linked a probiotic to a large reduction in eczema severity (SMD –4.24) — but the effect was strain-specific and the dose wasn't reported.
- 2025-06-03
- Systematic Review
- n = 502
- Frontiers in nutrition
This is a strong signal for Lactobacillus GG in children with food allergies, but the analysis relied on indirect comparisons and the results may not generalize to adults or to other strains like Bifidobacterium bifidum BB-06, which was included but not highlighted as the top performer.
Big effectBifidobacterium bifidum BB-06 for Improved Allergic Symptoms
A systematic review found synbiotic treatments linked to reduced painkiller use in migraine — alongside cuts in frequency, severity, and duration — though the evidence comes from only six, mostly small trials.
- 2025-05-21
- Systematic Review
- The journal of headache and pain
This is early but promising evidence that targeting the gut microbiome with pre- and probiotics might help manage migraine, but with few studies and no specified dose or long-term data, it's far from a settled recommendation.
New evidenceStreptococcus thermophilus PXN 66 for Reduced Painkiller Consumption
Vitamin E plus levocarnitine slashed cardiac event odds by 73% in chemo patients — but the combo was tested in only one small trial among 28 studies.
- 2025-09-03
- Systematic Review
- n = 858
- Frontiers in cardiovascular medicine
This is the first systematic review to flag this supplement pairing as potentially protective during anthracycline chemotherapy, but with just 858 patients across all trials and no specified dose, it’s a promising lead — not a recommendation.
New evidenceL-Carnitine for Reduced Cardiac Event
In an open-label trial of 874 pregnant women, 200 mg/day lactoferrin was linked to 75% fewer asymptomatic bacteriuria episodes — but the lack of blinding and narrow population demand caution.
- 2025-04-23
- RCT
- n = 874
- BMC urology
This is the first solid randomized trial on lactoferrin for urinary tract infections, but it was open-label (no placebo) and tested only in pregnant Egyptian women with recurrent UTIs, so the results may not apply to other groups and need replication.
New evidenceLactoferrin for Reduced Asymptomatic Bacteriuria Episode